Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Denmark Danish Medicines Agency approves medical cannabis oil product ...
  • Ohio - United States Bill to ban sale of intoxicating hemp products unlikely to move forward ...
  • Europe European Council adopts regulation to reduce and recycle packaging ...
  • Germany Two Berlin districts to start recreational cannabis sales ...
  • Nebraska - United States Two cannabis measures signed into law ...
  • Brazil AGU requests extension on deadline for cannabis regulations ...
  • Switzerland Bern recreational cannabis project extended ...
  • Japan Law in force today criminalises recreational and legalises medical cannabis ...
  • Germany ‘Not the second pillar’ as BMEL issues rules on cannabis research projects ...
  • France Restart of experiment on medical cannabis could be pushed to 2026 ...
  • Florida - United States Letters of intent to approve medical marijuana permits issued ...
  • Netherlands Experimental phase of controlled cannabis experiment starts 7th April ...
View all
Regulatory reports

South Korea: CBD and cannabis regulation, November 2022

Written by || 30th November 2022 || Regulatory reports | Cannabis – medical | Cannabis – recreational | Cosmetics | Food | Regulation and legislation | Vapour/Smokable | GeographiesAsia South Korea

The South Korean legislation does not make a clear distinction between hemp and cannabis, and the South Korean market for hemp-related products is heavily focused on medical cannabis.

This report provides a detailed overview of the regulatory framework in place for hemp, cannabinoids and cannabis, covering all policy areas from hemp cultivation and processing, CBD extracts, finished products and the country’s medical and recreational cannabis laws.

Free Sample

Download a free sample page of the report

South Korea: CBD and cannabis regulation, November 2022

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Sergi Riudalbàs Clemente

Legal analyst
Sergi holds a Master’s degree in European Union Law from the University of Amsterdam, where he also participated in the Fair Work and Equality Law Clinic. He graduated in Law from the University of Barcelona in 2019. He worked as a legal research intern at Global Human Rights Defence, an NGO that monitors human rights violations worldwide. He also engaged in a traineeship program in an Egyptian law firm in 2019, arranged by AIESEC.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.